Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical Bioequivalence of Wixela Inhub and Advair Diskus in Adults With Asthma

Published:2020-04-01 Issue:2 Volume:33 Page:99-107
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Ng Dik¹,Kerwin Edward M.²,White Martha V.³,Miller S. David⁴,Haughie Scott¹,Ward Jonathan K.¹,Allan Richard¹

Affiliation:

1. Mylan Pharma UK Ltd., Sandwich, Kent, United Kingdom.

2. Clinical Research Institute of Southern Oregon, Medford, Oregon.

3. Institute for Asthma and Allergy, Wheaton, Maryland.

4. Northeast Medical Research Associates, Inc., North Dartmouth, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jamp.2019.1547

Reference18 articles.

1. Salmeterol/Fluticasone Propionate

2. Dose-Ranging Study to Evaluate the Efficacy and Safety of Four Doses of Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler (FS MDPI) Compared with Fluticasone Propionate (Fp) Mdpi and FS DPI in Subjects with Persistent Asthma

3. ATS Core Curriculum 2017: Part III. Adult Critical Care Medicine

4. Ten Principles to Guide Health Reform

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Bioequivalence between Generic and Originator Orally Inhaled Drug Products: Validity of Administration of Doses above the Approved Single Maximum Dose;Molecular Pharmaceutics;2024-08-12

2. Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease;Annals of Internal Medicine;2024-01

3. Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component;Molecular Pharmaceutics;2023-11-09

4. Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease;Annals of Internal Medicine;2023-08

5. Pulmonary;Practical Pharmaceutics;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3